Goldenberg Gary has filed 7 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 50000 shares of Verrica Pharmaceuticals Inc. ($VRCA) on August 24, 2023.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 24, 2023 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 120,110.0000 | 0 | 71.32% | 0.00% |
| Aug. 26, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | Chief Medical Officer | S | Common Stock | 9888 | $2.66 | 97,862.0000 | 0 | 9.18% | 0.00% |
| Aug. 27, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | Chief Medical Officer | S | Common Stock | 3601 | $2.46 | 94,261.0000 | 0 | 3.68% | 0.00% |
| July 23, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | Chief Medical Officer | S | Common Stock | 86 | $6.98 | 107,750.0000 | 0 | 0.08% | 0.00% |
| July 22, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | Chief Medical Officer | S | Common Stock | 18421 | $7.06 | 107,836.0000 | 0 | 14.59% | 0.00% |
| March 15, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Goldenberg Gary | CHIEF MEDICAL OFFICER | A | Common Stock | 40000 | $0.00 | 126,257.0000 | 0 | 46.37% | 0.00% |